Kyle Piskel - Net Worth and Insider Trading
Kyle Piskel Net Worth
The estimated net worth of Kyle Piskel is at least $3 Million dollars as of 2025-07-23. Kyle Piskel is the CFO of Adaptive Biotechnologies Corp and owns about 277,396 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $3 Million. Details can be seen in Kyle Piskel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kyle Piskel has not made any transactions after 2025-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kyle Piskel
Kyle Piskel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kyle Piskel owns 1 companies in total, including Adaptive Biotechnologies Corp (ADPT) .
Click here to see the complete history of Kyle Piskel’s form 4 insider trades.
Insider Ownership Summary of Kyle Piskel
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2025-05-16 | Principal Accounting Officer |
Kyle Piskel Latest Holdings Summary
Kyle Piskel currently owns a total of 1 stock. Kyle Piskel owns 277,396 shares of Adaptive Biotechnologies Corp (ADPT) as of May 16, 2025, with a value of $3 Million.
Latest Holdings of Kyle Piskel
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2025-05-16 | 277,396 | 10.71 | 2,969,524 |
Holding Weightings of Kyle Piskel
Kyle Piskel Form 4 Trading Tracker
According to the SEC Form 4 filings, Kyle Piskel has made a total of 10 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 1,929 shares on May 16, 2025, which brought Kyle Piskel around $17,149.
Insider Trading History of Kyle Piskel
- 1
Kyle Piskel Trading Performance
Kyle Piskel Ownership Network
Ownership Network List of Kyle Piskel
Ownership Network Relation of Kyle Piskel
Kyle Piskel Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Kyle Piskel is the Principal Accounting Officer of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include Chief Scientific Officer Harlan S Robins , director & CEO and Chairman Chad M Robins , and SVP & Diagnostics & clonoSEQ Susan Bobulsky .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Kyle Piskel made 5 insider transaction in Adaptive Biotechnologies Corp (ADPT) with a net sale of 22,153. Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 1,023,797 shares made by Chad M Robins , a net sale of 166,766 shares made by Harlan S Robins , and a net sale of 98,575 shares made by Julie Rubinstein .
In summary, during the past 3 months, insiders sold 72,270 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 72,270 shares. During the past 18 months, 1,630,649 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630,649 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Kyle Piskel Mailing Address
Above is the net worth, insider trading, and ownership report for Kyle Piskel. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kyle Piskel's mailing address is: Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
